Researchers at MIT have unveiled a way to temporarily reboot aging immune systems, using a targeted mRNA therapy that turns the liver into a short‑lived factory for powerful T‑cell survival signals.

Jazz’s Ziihera and BeOne’s Tevimbra plus chemotherapy led to what Truist Securities dubbed one of the strongest overall ...

MILAN and NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Genenta Science (GNTA), a pioneer in immuno-oncology, today announced that a total of 38 patients were enrolled in newly diagnosed glioblastoma ...

Bria-IMT plus a checkpoint inhibitor showed a 52% one-year survival rate in metastatic breast cancer patients, surpassing standard therapy outcomes. The treatment was well-tolerated, with no ...